Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
41.21
-0.91
(-2.16%)
At close: 2:56:25 PM GMT+8
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Minmin Yang Ph.D. | Co-Founder, Chairman & CEO | -- | -- | 1972 |
| Ms. Wu Yifei | Secretary, CFO & Accounting Supervisor | -- | -- | 1979 |
| Dr. Shijie Zhang Ph.D. | Chief Technology Officer | -- | -- | 1964 |
| Dr. Jing Li Ph.D. | Sr. VP of Process Chemistry & President of PharmaBlock (USA), Inc. | -- | -- | 1973 |
| Dr. Shuhai Zhao Ph.D. | Co-founder & Chief Scientific Officer | -- | -- | 1963 |
| Dr. David Chen Ph.D. | Executive VP, Chief Operation Officer & Head of CDMO | -- | -- | -- |
| Dr. Dezhi Sha Ph.D. | Sr. VP of Process Technology & Manufacturing | -- | -- | -- |
PharmaBlock Sciences (Nanjing), Inc.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
- Full Time Employees:
- 2,455
Description
PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.
Corporate Governance
PharmaBlock Sciences (Nanjing), Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
June 14, 2024 at 12:00 AM UTC
Ex-Dividend Date